about
Gastric cancer after positive screening faecal occult blood testing and negative assessmentEuropean guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)Chest X-ray survey in the follow-up of breast cancer patients.Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme.Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme.Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study).Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?Acceptability and side-effects of colonoscopy and sigmoidoscopy in a screening setting.Colorectal cancer mortality in two areas of Tuscany with different screening exposures.Impact of a new sampling buffer on faecal haemoglobin stability in a colorectal cancer screening programme by the faecal immunochemical test.Effect of rehydration on guaiac-based faecal occult blood testing in colorectal cancer screening.High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy."Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data." by Moayyedi P and Achkar E.Cervical cancer screening visit as an occasion for counseling female smokers to quit.Trends in cervical cancer incidence in the district of Florence.Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes.Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.Reduced and Full-Preparation CT Colonography, Fecal Immunochemical Test, and Colonoscopy for Population Screening of Colorectal Cancer: A Randomized Trial.Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.Computed tomographic colonography in subjects with positive faecal occult blood test refusing optical colonoscopy.Sensitivity of screening sigmoidoscopy for proximal colorectal tumours.Comparing Different Strategies for Colorectal Cancer Screening in Italy: Predictors of Patients’ ParticipationCorrigendum to “A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomized controlled trial in population-based screening programmes” [Prev. Med. 65 (2014) 70–The impact of immunochemical faecal occult blood testing on colorectal cancer incidenceFamilial risk of colorectal cancer in subjects attending an organised screening programmeThe Authors' replyAuthors' responseThe Authors' replyCT colonography before colonoscopy in subjects with positive faecal occult blood test. Preliminary experienceInfluence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence districtColorectal cancer screening programme by faecal occult blood test in Tuscany: first round resultsFeasibility study of colorectal cancer screening by immunochemical faecal occult blood testingBasic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult bloodScreening for colorectal cancer by faecal occult blood test: comparison of immunochemical testsCorrespondenceTamoxifen: the need for a monitoring protocolCancer screening in the European UnionUltrasonography surveillance of endometrium in breast cancer patients on adjuvant tamoxifen
P50
Q28289391-1AEC34C0-7800-47DE-91F0-96134950613AQ30485842-31CB574C-A654-4295-9752-FD7FDBD9EA0DQ34543764-D8C224C1-7DD2-4BA2-B4A4-2EF24E9404FBQ36468041-4CF88358-1926-4068-B10D-71E230F32CE6Q36609425-E7C60201-1841-44B4-B89D-2DCEE555D1AFQ36609690-EDC41437-35D3-438C-A2E9-2EC0CEEAC1BEQ36744627-25741DFF-A29D-46EE-A00B-20FA9ACF6CE9Q37081068-BBD9D40B-D542-4A1B-8227-E268D1BDE483Q37951885-8306D8BB-25EE-4530-9421-83E2CA21BF92Q38452884-FC4E55E9-D4BD-423E-9ED8-E7D539C3431EQ40714692-7A5BEBAF-F33A-4E29-9D62-05292957C0F8Q41934326-8AC784D6-5CB1-4035-90E6-6A4AC074CE6CQ43428341-56A30843-E063-466B-9E69-380D38E87D5EQ44081633-931BD7BA-F3F4-4D04-84AF-4FEDE673DFB2Q45011946-EF90109D-3E38-473A-8CB2-7191E904CC5CQ45064223-0004FCC8-803D-43BE-9509-D461301B53F0Q46128710-7607432D-8D88-4BBE-B6C2-F7C87A5FAA80Q46446775-33987812-AEFC-451B-9D70-1E1679F08719Q50615394-43E39608-E15F-449A-9C5B-37E578E7DB25Q50896775-DFDC2F70-FABB-4A87-A37F-E4EFF7E0C384Q51506480-BDE129A6-7726-4395-9A27-79734ACB023AQ53127325-B7ED8313-79F1-46A6-A5B6-C492A44010DBQ53889340-572668A0-06CA-45AF-B005-FD7595847992Q59193578-DE1CD16A-72F5-4D73-8EFD-BA3EABF882C0Q59193653-1783E477-2AC9-4768-902D-057636576EB0Q59193655-214A39A4-3FBB-4A51-AE99-D43BA0031470Q59193656-EAEC9304-6B23-4F19-9A09-058506859053Q59193658-A6D7C4E3-0984-46BC-AC0C-3235DB4C5281Q59193660-8A3BC79D-F279-4883-A8A6-59AC88796604Q59193661-47AA03BC-7872-4075-B81B-330A90E252EFQ59193664-CEADBD8C-CB96-4BA3-BE86-4B99427D6267Q59193665-B92DC75B-BD34-43F3-9230-42BF95E9BC80Q59193669-C91FE123-42CA-403B-BB7D-4C1A4FDC206AQ59193670-D8D3E465-3463-4B3C-889C-935EA40DB986Q59193671-64F08FCD-861A-419B-BD0B-A73303B2D69DQ59193674-841D3985-6987-4202-98C3-DAB0A0470B84Q59193675-3C9EC1C1-3092-419A-B5E3-A6988B8F2678Q59193679-CFAD420D-AA95-4982-8B43-2C8E4B777856Q59193681-CC4E6B7E-7F78-4EDB-B9B6-8B534190B143Q59193682-0700B61C-6A5E-4470-B1CA-C4ACD3663CD8
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
G Grazzini
@nl
Grazia Grazzini
@en
Grazia Grazzini
@es
type
label
G Grazzini
@nl
Grazia Grazzini
@en
Grazia Grazzini
@es
altLabel
G Grazzini
@en
prefLabel
G Grazzini
@nl
Grazia Grazzini
@en
Grazia Grazzini
@es
P1053
K-8503-2016
P106
P1153
57190083213
P21
P31
P3829
P496
0000-0002-9713-3007